INDV Indivior Pharmaceuticals, Inc.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$1.83B
Revenue (FY)
$1.24B 2025-12-31
Net Income (FY)
$210.00M
P/E (float-based)
8.7
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official